Delivery Order SPE2DB20D2104-SPE2DB25FMZNF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperidone 3 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of approximately $2.1K. The award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-competitive delivery order executed through AmerisourceBergen's existing indefinite delivery contract vehicle with DLA. Performance will occur at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,054.47 to AmerisourceBergen Drug Corp for the supply of Risperidone 2 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on April 24, 2025, with an ultimate completion date of April 25, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,029.30 by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Risperidone 3 mg tablets in quantities of 60 units. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is expected to be completed by August 18, 2025, with performance taking place at the vendor's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,046.40 to AmerisourceBergen Drug Corp for the supply of Risperdal 0.5 mg tablets (60-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Risperidone 0.5 mg tablets in a 60-count quantity, with a ceiling value of $1,310.34. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Risperidone 3 mg tablets (60-count packages) with a ceiling value of $3.07K. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 29, 2025. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.86 to AmerisourceBergen Drug Corp for 500 tablets of Risperidone 0.25 mg. This contract, issued on June 20, 2025, with an ultimate completion date of June 23, 2025, is a firm fixed price delivery order with no set-aside designation. The award reflects a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX and valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Risperdal 0.5 mg tablets (60 count) with a ceiling value of $3,787.60. This competitively awarded, firm fixed-price delivery order is set to be completed by August 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Risperidone 3 mg tablets in a quantity of 60 units, with a ceiling value of $1,816.53 and a firm fixed-price contract type. The order is not set-aside and represents a competitive award to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June...
- The Defense Logistics Agency awarded a delivery order valued at $1,037.00 to AmerisourceBergen Drug Corp for the supply of Risperdal (risperidone) 0.5 mg tablets in a quantity of 60 tablets. The contract was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025, utilizing firm fixed-price pricing with no set-aside designation. Performance of this delivery will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMZNFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,275.84 to AmerisourceBergen Drug Corp for Risperidone 3 mg tablets (60-count units) on September 4, 2025, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and represents a routine pharmaceutical supply transaction for federal medical operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for the Defense Logistics Agency's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC vehicle enables the contractor to supply pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The award reflects the company's established capability to fulfill federal pharmaceutical procurement requirements and its role within the DLA's broader pharmaceutical supply chain supporting Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/4/25 |